| CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity F Chu, HS Li, X Liu, J Cao, W Ma, Y Ma, J Weng, Z Zhu, X Cheng, Z Wang, ... Leukemia 33 (11), 2640-2653, 2019 | 52 | 2019 |
| GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice C Chen, X Li, G Ge, J Liu, KC Biju, SD Laing, Y Qian, C Ballard, Z He, ... Scientific reports 8 (1), 5460, 2018 | 46 | 2018 |
| Multimodal MRI evaluation of the MitoPark mouse model of Parkinson’s disease L Cong, ER Muir, C Chen, Y Qian, J Liu, KC Biju, RA Clark, S Li, ... PloS one 11 (3), e0151884, 2016 | 31 | 2016 |
| Regulatable lentiviral hematopoietic stem cell gene therapy in a mouse model of Parkinson's disease G Ge, C Chen, MJ Guderyon, J Liu, Z He, Y Yu, RA Clark, S Li Stem cells and development 27 (14), 995-1005, 2018 | 14 | 2018 |
| Platelet activating factor-induced expression of p21 is correlated with histone acetylation E Damiani, N Puebla-Osorio, BM Lege, J Liu, SS Neelapu, SE Ullrich Scientific reports 7 (1), 41959, 2017 | 11 | 2017 |
| Immortalized B cells transfected with mRNA of antigen fused to MITD (IBMAM): an effective tool for antigen-specific T-cell expansion and TCR validation Z Wang, T Zhang, A Anderson, V Lee, S Szymura, Z Dong, B Kuang, E Oh, ... Biomedicines 11 (3), 796, 2023 | 7 | 2023 |
| Targeting CAR T resistance due to CD19 loss with CD79b-specific CAR T cells in B-cell malignancies F Chu, J Weng, SQ Kuang, X Cheng, JJ Cao, J Liu, S Karri, A Reddy, ... Blood 132, 1662, 2018 | 4 | 2018 |
| Combination therapy with BTK inhibitor plus anti-PD-1 antibody results in a hyperprogressor phenotype in a mouse model of CLL A Gu, H Ma, X Zhang, P Malaney, M Gallardo, J Liu, SS Neelapu, SM Post Blood 132, 4416, 2018 | 3 | 2018 |
| Development of a Novel Platform for in-Vitro Immune-Monitoring of Antigen-Specific T Cells and Discovery of Novel Antigen-Specific TCRs Using Immortalized B Cells Transfected … T Zhang, Z Wang, S Cha, A Anderson, J Liu, Z Dong, S Szymura, B Kuang, ... Blood 140 (Supplement 1), 4699-4700, 2022 | | 2022 |
| 296 Targeting B-cell malignancies with anti-ROR1 CAR T-cell therapy J Weng, O Agbedia, J Cao, X Cheng, SQ Kuang, F Chu, S Patchv, Y Tang, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| A Modified lentiviral vector construction system B Song, JW Liu, XF Chen, YM Xu Life Science Journal 7 (2), 42-46, 2010 | | 2010 |
| Immortalized B cells transfected with mRNA of Antigen fused to MITD (IBMAM): an effective immunological tool for in-vitro immune-monitoring of antigen-specific T cells PD Zhe Wang, PD Soung-Chul Cha, PD Jingwei Liu, PD Zhenyuan Dong, ... 10th Annual Symposium on Global Cancer Research (Posters), 0 | | |
